Virbactan 150 mg intramammary ointment
Virbactan 150 mg intramammary ointment
Awtorizzat
- Cefquinome sulfate
Identifikazzjoni tal-prodott
Dettalji tal-prodott
Sustanza attiva / Qawwa:
-
Disponibbli biss fi English150.00milligram(s)3.00gram(s)
Forma farmaċewtika:
-
Suspensjoni intramammarja
Withdrawal period by route of administration:
-
Użu intramammarju
- Cattle (dairy cow at drying-off)
-
Meat and offal2day
-
Milk1day1 ден след отелването, когато сухостойният периоднад 5 седмици
-
Milk36day36 дни след лечението, когато сухостойният период е 5 или по-малко седмици
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QJ51DE90
Status tal-awtorizzazzjoni:
-
Valid
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Virbac
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Haupt Pharma Latina S.r.l.
- VIRBAC
Awtorità responsabbli:
- Bulgarian Food Safety Authority
Numru tal-awtorizzazzjoni:
- 0022-1507
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumenti
Sommarju tal-karatteristiċi tal-prodott
Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
Bulgarian (PDF)
Ippubblikat fuq: 28/03/2024
Package Leaflet and Labelling
Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
Bulgarian (PDF)
Ippubblikat fuq: 28/03/2024
Kemm kienet utli din il-paġna?: